A typical protocol involves 1 to 2 mg GHK-Cu subcutaneously, administered 30 minutes before bed
Some people use oral tablets, gummies, liquids, or sublingual products
When used appropriately, peptides are generally well tolerated for many patients, though most are not FDA approved
# # # BPC-157 went into human trials in Europe years ago under a code name, PL 14736, run by the Croatian drug maker Pliva
Whether you are new to compounded tirzepatide or months into your protocol, the information here will help you protect your investment and your results
The phosphorylated form is also relevant to pharmacokinetics: unmodified DSIP is cleaved rapidly in circulation, whereas the phospho-serine variant is more metabolically stable